Download Referencias bibliográficas - BVS Cuba

RCP 4-03
Referencias bibliográficas
T-1
Referencias bibliográficas
1. Rangel M. Complicaciones cardiacas en la insuficiencia renal crónica en: Hernardo Avendaño
L. Nefrología Clínica. Ed. Médica Panamericana, 1998.
2. Orejas G, Cobo A. Fallo renal crónico. Generalidades En: García Nieto V, Santos F. eds.
Madrid: Grupo de Aula Médica S.A. Nefrología Pediátrica, 2000: 279-83.
3. Nicholls AJ. Corazón y circulación: En Dougerdes JT. Manual de Diálisis. Masson Litles
Brown, 1996: 585-601.
4. López Gómez JM, Jofre R, Cases A. Cardiovascular risk factors in chronic renal failure.
Nefrología 2002; 22 suppl.1: 59-67.
5. Cases A, Vera M, López Gómez JM. Cardiovascular risk in patients with crhonic renal failure.
Patients in renal replacement therapy. Nefrología 2002; 22 suppl 1: 68 -74.
6. Saland JM, Ginsberg H, Fisher EA. Dyslipidemia in pediatric renal disease: Epidemiology,
pathophysiology and management. Curr Opin Pediatr 2002; 14:197-204.
7. Levin A, Stevens L, Mc Cullough PA. Cardiovascular disease and the kidney. Tracking a killer
in chronic kidney disease. Postgrad Med 2002; 111:53-60.
8. Fernández Andrade C. Renal markers and predictors in renal and cardiovascular risk factors.
Nefrología 2002; 22 suppl 1:2 -29.
9. Obrador GT, Pereira BJ. Systemic complications of chronic kidney disease. Postgrad Med
2002; 111:115-22.
10. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke Sk, et al. Cardiac calcification
in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular
disease? J Am Coll Cardiol 2002; 20:39.
11. Tazawa M, Iseki K, Iseki C, Takishita S. Pulse Pressure and risk of total mortality and
cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002; 61:717- 26.
12. Mathur S, Devaraj S, Jialal L. Accelerated atherosclerosis, dyslipidemia, and oxidative stress in
end-stage renal disease. Curr Opin Nephrol. Hypertens 2002; 11:141-7.
13. Jacobson Sh, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of
endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22:42.
14. Ivens K, Gradaus F, Heering P, Schoebel FC, Klein M. Schulte HD, et al. Myocardial
revascularization in patients with end-stage renal disease: comparison of percutaneous
transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol. Nephrol 2001;
32:717-23.
15. Dikow R, Zeier M, Ritz Z. Cardiovascular abnormalities and hypertension in the elderly
dialysis patients. Semin Dial 2002;15:121-6.
16. Atalay S, Ekim M, Tutar HE, Kocak G, Bakkaloglu S, Turner N. Systolic and diastolic function
in children with chronic renal failure. Pediatr Int 2002; 44:18-23.
17. London GM, Uremic cardiomyopathy. An inadequate left ventricular hypertrophy. Kidney Int
1987; 31: 973-8.
18. Foley RN Left ventricular hypertrophy in dialysis patients. Semin Dial 1992; 5:34-9.
19. Cressman MD. Lipoprotein in an independent risk factor for cardiovascular disease in
hemodialysis patients. Circulation 1992; 86:475-9.
20. D’Amico G, Sanna G. Symposium on lipid abnormalities in renal disease. Kidney Int
1999(suppl); 31: 51.
Recibido: 1 de agosto de 2003. Aprobado: 29 de septiembre de 2003.
Dra. Neri G. Campañá Cobas. Hospital Pediátrico Universitario “William Soler”, San
Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.
T-2
Referencias bibliográficas
1. Williams H, Johson K.Imaging of congenital cystic lung lesions. Paediatr Respir Rev
2002; 3(2):120.
2. Roberts PA, Holland AJ, Halliday RJ, Arbuckle SM, Cass DT. Congenital lobar
emphysema: Like father, like son. J Pediatr Surg 2002 May, 37(5):799-801.
3. Rusakow LS, Khare S. Radiographically occult congenital lobar emphysema presenting
as unexplained neonatal tachypnea. Pediatr pulmonol 2001 Sep; 32(3): 246-9.
4. Babu R, Kyle P, Spicer RD. Prenatal sonographic features of congenital lobar
emphysema. Fetal Diagn Ther 2001 Jul-Aug; 16(4):200-2.
5. Quinton AE, Smoleniec JS. Congenital lobar emphysema –the disappearing chest mass:
antenatal ultrasound appearance. Ultrasound Obstet Gynecol 2001 Feb; 17(2): 169-71.
6. Lacy DE, Shaw NJ, Pilling DW, Walkinshaw S. Outcome of congenital lung
abnormalities detected antenatally. Acta Paediatr 1999 Apr; 88(4):454-8.
7. Van Koningsbruggen S, Ahrens F, Brockmann M, Michalk D, Rietschel E. Congenital
cystic adenomatoid malformation type 4. Pediart Pulmonol 2001 Dec; 32 (6):471-5.
8. Thompson AJ, Reid AJ, Reid M. Congenital lobar emphysema occurring in twins. J
Perinat Med 2000; 28(2):155-7.
9. Olutoye O, Coleman BG, Hubbard AM, Adzick NS. Prenatal diagnosis and
management of congenital lobar emphysema. J Pediatr Surg 2000 May; 35 (5):792-5.
10. Karnak I, Senocak ME, Ciftci AO, Buyukpamukcu N. Congenital lobar emphysema:
diagnostic and therapeutic considerations. J Pediatr Surg 1999 Sep; 34 (9):1347-51.
11. Al-Bassam A, Al-Rabeeah A, Al-Nassar S, Al-Mobaireek K, Al-Rawaf A, Banjer H.
Congenital cystic disease of the lung in infants and children (experience with 57 cases).
Eur J Pediatr Surg 1999 Dec; 9(6):364-8.
12. Cay A, Sarihan H. Congenital malformation of the lung. J Cardiovasc Surg (Torino)
2000 Jun; 41(3):507-10.
13. Al- Salem AH. Congenital lobar emphysema. Saudi Med J 2002 Mar; 23 (3): 335-7.
14 Thakral CL, Maji DC, Sajwani MJ. Congenital lobar emphysema: experience with 21
cases. Pediatr Surg Int 2001 Mar; 17(2-3):88-91.
15. Bappal B, Ghani SA, Chaudhary R, Sajvani MJ. Congenital lobar emphysema : a
review of 10 cases. Indian J Pediatr 1996 Nov-Dec; 63(6):801-8.
16. Dogan R, Demircin M, Sarigul A, Pasaoglu I, Gocmen A, Bozer AY. Surgical
management of congenital lobar emphysema. Turk J Pediatr 1997 Jan-Mar; 39(1): 3544.
17. Keidar S, Ben-Sira L, Weinberg M, Jaffa AJ, Silbiger A, Vinograd I. The postnatal
management of congenital cystic adenomatoid malformation. Isr Med Assoc J 2001
Apr; 3(4):258-61.
Recibido: 24 de diciembre de 2002. Aprobado: 26 de febrero de 2003.
Dr. Ruperto Llanes Céspedes. Juan Lefont No.8 entre Johnson y Libertad. 10 de Octubre.
Ciudad de La Habana, Cuba.
T-3
Referencias bibliográficas
1. Frezza EE. Girnys RP, Silich RJ, Coppa GF. Commentary quality of care and costs
containment are the hospital-based ambulatory surgery challenges for the future. Am J
Med Qual 2000;15:114-8.
2. Mezei B, Chung F. Return hospitals visits and hospital readmission after ambulatory
surgery. Ann Surg 1999; 230(5):721-7.
3. Patel RI, Verghese ST, Hannallah RS, Aregawi H, Patel KM. Fast tracking children
after ambulatory surgery. Anesth Analg 2001; 92(4): 918-22.
4. Munro HW, Malviya S, Lauder GR, Voepel Lewis T, Tait AR. Pain relief in children
following outpatient surgery. J Clin Anesth 1999; 11(3): 187-9.
5. Cloud DT. Major ambulatory surgery of the pediatric patient. En: Davis JE (ed.).
Baltimorew Milliams Wilkins, 1986:367.
6. Morse TS. Pediatric out patient surgery. J Pediatric Surg 1972:283.
7. Othersen HB, Clatworthy HW, Jr: Out patient herniorraphy for infants. Am J Dis Chile
1988:78.
Recibido: 23 de abril de 2003. Aprobado: 8 de julio de 2003.
Dr. Arturo L Delgado Delgado. Hospital Pediátrico Universitario “San Miguel del
Padrón”, San Miguel del Padrón, Ciudad de La Habana, Cuba.
T-4
Referencias bibliográficas
1. Gary Cunningham F, Mac Donald PC, Grant NF, Leveno KJ, Gilstrap III LC, Hankins GDV,
et al. En: Williams, Obstetricia 20, ed. Buenos Aires: Ed. Medica Panamericana, 1998: 44362.
2. Colectivo de autores. Manual de diagnóstico y tratamiento en Obstericia y Perinatología. La
Habana: Ed. Ciencias Médicas, 2000: 460-70.
3. Reeder Sharon J, Martin Leonide L, Koniak D. Parto vaginal asistido con instrumentos. En:
Enfermería materno-infantil. 17 ed. Mexico: Nueva Editorial Interamericana, 1995: 1007-12.
4. Carrera Macía JM. Protocolos de Obstetricia y Medicina Perinatal del Instituto Dexeaus. 2da
ed. España: Salvat editores, 1988: 266-8.
5. Botella Llusiá J, Clavero Nuñez JA. Tratado de Ginecología y Obstetricia. 2da. Ed.
Barcelona: Científico Médico de Barcelona, 1993: 853-888; t. 2.
6. Behrman RE, Kliegman RM, Harbin AM. Tratado de Pediatría. Nelson. 15 ed. La Habana:
Ed. Ciencias Médicas, 1998: 583-4; t.
7. Ordás J. La extracción fetal mediante espátulas de Thierry. Toko Ginecol marzo 1990: 10911.
8. Perales A. La instrumentación vaginal en el sufrimiento fetal agudo. Rev Esp Obstetricia
Ginecol 1998; 47: 205-10.
Recibido: 3 de septiembre de 2002. Aprobado: 19 de octubre de 2002.
Dra. Rosa M. Alonso Uría. Avenida 101, No. 20 804, entre Blanco y Villa Rosa, Las
Granjas, Cotorro, Ciudad de La Habana, Cuba.
T-5
Referencias bibliográficas
1. De Juan Martín F. Impacto de la inmunización frente a la enfermedad invasora por
neumococo: vacuna neumocócica conjugada. An Esp.Pediatr 2002;57:24-30.
2. Perez AE, Dickinson FO, Baly A, Martínez R. The epidemiologycal impact of
antimeningococcal B vaccination in Cuba. Mem Inst. Oswaldo Cruz 1999;94(4):433-40.
3. Dickinson F, Pérez A, Galindo MA, Quintana I. Impacto de la vacunación contra
Haemophilus influenzae tipo b en Cuba. Rev Panam Salud Pública 2001;(3):169-74.
4. Dickinson FO, Pérez AE. Las meningoencefalitis bacterianas en la población infantil
cubana:1998-2000. Rev Cubana Pediatr 2002;75 (2):106-14.
5. Dirección Nacional de Estadísticas. MINSAP. .Anuario Estadístico de Salud, 2001.
6. Otero Reigada MC, Pérez Tamarit D, Asensi Boted F. Meningitis bacterianas. En: Protocolos
diagnósticos y terapéuticos en Pediatría. Tomo 2. .Infectología. Asociación Española de
Pediatría, Madrid, 2001:149-55.
7. Sáez-Llorens X. Nuevas perspectivas en meningitis bacteriana. An Esp Pediatr 2001;54 (supl
4):401-2.
8. -----------------. Patogénesis de la meningitis bacteriana. Implicaciones terapéuticas. An
Esp.Pediatr 2002;57:14-8.
9. Alvez F. Meningitis bacteriana. En: Castro Gago M. Tratamiento de las enfermedades
neurológicas en niños y adolescentes. Barcelona: Ed Espaxs. 1999: 119-25.
10. Asensi Botet F. Tratamiento de las meningitis bacterianas. An Esp.Pediatr 2002;57: 19-23.
11. Saens-Llorens X, Mc Cracken GH. Antimicrobial and anti inflammatory treatment of
bacterial meningitis. Infect Dis Clin North Am 1999;13:619.
12. Kaplan SL. Adjuvant therapy in meningitis. Adv Pediatr Infect Dis 1995;10:167-86.
13. Casado J. Meningitis aguda en la infancia. En: F. Rusa. Tratado de Cuidados Intensivos
Pediátricos, 2 ed. Madrid: Ed Norma, 1994:888-904.
14. Martin Ancel A, García Alix, Quero J. Meningitis bacteriana: mecanismos de daño cerebral y
nuevas aproximaciones terapéuticas. An Esp Pediatr 1997;47:126-34.
15. Colectivo de autores. Programa Nacional de Prevención y Control de Síndromes
Neurológicos Infecciosos. La Habana: MINSAP, 1999:18-21.
16. Singhi S. Fluid restriction and intracraneal presure during bacterial meningitis: To restrict
fluid or not. 10th International Congress on Infection Diseases. Singapore, 14 de marzo de
2002, Book of Abstracs,130.
17. Colectivo de autores. Guías de práctica clínica. Terapia intensiva pediátrica. La Habana: Ed
Política, 2001, capítulo 4: Agua y electrólitos: 33-69.
18. ---------------------. Guías de práctica clínica. Terapia intensiva pediátrica. La Habana: Ed
Política, 2001,capítulo 6: Sepsis: 89-103.
19. Llop A, Tamargo I, Ramírez M, Pérez M, Toraño G, Ramírez M, et al. Resistencia a los
antimicrobianos y vigilancia microbiológica en Cuba. Rev Panamericana de Infectología,
1999; 3(Supl 1):33-40.
20. Del Valle Ortiz O, Streptoccocus pneumoniae y resistencia a los antimicrobianos. En:
Moraga Llop F, editor. La enfermedad neumocócica en el niño, 1era ed. Barcelona: Prous
Science, 2001: 69-79.
21. Saez-Llorens X, McCoig C, Ferris JM. Quinolone treatment for pediatric bacterial
meningitis: A comparative study of trovefloxacin and ceftriaxone with or without
vancomicyn. Pediatr Infect Dis J2002;21:14-22.
22. Mitchell L, Toumanen E. Vancomycin tolerant S. pneumoniae and its clinical significance.
Pediatr Infec Dis.J.2001;12:531.
23. Tamargo I, Toraño G, Pérez M, Fuentes K, Llop A, et al. Susceptibilidad antimicrobiana en
cepas de Haemophilus influenzae y Streptococcus pneumoniae circulantes en Cuba. Revista
Latinoamericana de Microbiología 2000;42:603.
24. Craig WA. Pharmacokinetics/pharmacodynamics parameters: Rationale for antibacterial
dosing of mice and men. Clin Infect Dis1998;26:1.
25. Craig WA. Relationship between pharmacokinetics and pharmacodynamics in determining
dosage regimens for cephalosporin. .Diagn Microbiol Infect Dis 1995;22:89.
26. McIntyre PB, Berkey CS, King SM. Dexamethasone as adjunctive therapy in bacterial
meningitis: A metaanalysis of randomized clinical trials since 1988. JAMA 1997;278:925.
Recibido: 23 de marzo de 2003. Aprobado: 4 de julio de 2003.
Dr. Roberto Alvarez Fumero. Hospital Pediátrico Universitario Centro Habana. Benjumeda esq.
Morales, Cerro, Ciudad de La Habana, Cuba.
Email: fumero@ msp.sld.cu
T-6
Referencias bibliográficas
1. Acute Respiratory infections: the forgotten pandemic. Communique from the
international conference on acute respiratory infections, held in Canberra, Australia,
710 July 1997. Int J Tuberc Lung Dis 1998; 2(1):2-4.
2. McCracken GH Jr.
Etiology and treatment of pneumonia. Pediatr Infect Dis J
2000;19(4):373-7.
3. Hinman A.
Eradication of vaccine-preventable diseases. Annu Rev Public Health
1999;20:211-29.
4. Monto AS, Lehmann D. Acute respiratory infections (ARI) in children: prospects for
prevention. Vaccine 1998;16(16):1582-8.
5. Breiman RF, Butler JC, McInnes PM.
Vaccines to prevent respiratory infection:
Opportunities on the near and far horizon. Curr Opin Infect Dis 1999;12:145-52.
6. Ottolini MG. Current and future use of vaccines for viral and bacterial respiratory tract
infections. Curr Infect Dis Rep 2000;2(2):121-9.
7. Salgado HV. Manual de la inmunización humana. Medellín: Ed. Médica Colombiana,
2001;75-185.
8. Couch RB. Infuenza: prospects for control. Ann Intern Med 2000 Dec 19;133(12):9928.
9. Poehling KA, Edwards KM. Prevention, diagnosis, and treatment of infuenza: current
and future options. Curr Opin Pediatr 2001;13(1):60-4.
10. Saito T, Tashiro M. Vaccines and therapeutics against influeza virus infections. Pediatr
Int 2000;42(4):219-25.
11. Luscher-Mattli M. Influenza chemotherapy: a review of the present state of art and of
new drugs in development. Arch Virol 2000;145(11):2233-48.
12. Gaillat J. What is current opinion of antiviral therapy for the flu in 2001? Rev Med
Interne 2001;22(1):53-61.
13. Woodhead M, lavanchy D, Johnston S, Colman P, Fleming D.
Neuraminadase
inhibitors: progress in the management of influenza. Int J Clin Pract 2000;54(9):604-10.
14. Mossad SB. Prophylactic and symptomatic treatment of influeza, current and
developing options. Postgrad Med 2001;109(1):97-105.
15. Prince GA. An update on respiratory suyncytial virus antiviral agents. Expert Opin
Invest Drugs 2001;10(2):297-308.
16. Greenough A, Thomas M. Respiratory syncytial virus prevention: past and present
strategies. Expert Opin Pharmacother 2000;(6):1195-201.
17. Kneyber MC, Moll HA, de Groot R. Treatment and prevention of respiratory syncytial
virus infection. Eur J Pediatr 2000;159(6):399-411.
18. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE, Boyce TG, et al.
Temperatura-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect
Dis 2000;182(5):1331-42.
19. Kahn JS. Respiratory sincytial virus vaccine development. Curr Opin Pediatr
2000;12(3):257-62.
20. Goetsch L, Plotnicky-Gilquin H, Champion T, Beck A, Corvaia N, Stahl S, et al.
Influence of administration dose and route on the immunogenicity and protective
efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine
candidate. Vaccine 2000;18(24):2735-42.
21. Sawyer LA. Antibodies for the prevention and treatment of viral diseases. Antiviral Res
2000;47(2):57-77.
22. Shigeta S. Recent progress in antiviral chemotherapy for respiratory syncytial virus
infections. Expert Opin Investig Drugs 2000;9(2):221-35.
23. McKim-Breschkin J. VP-14637 viroPharma. Curr Opin Investig Drugs 2000;1(4):4257.
24. Petrescu AL, Petica M, Barnaure F, Athanasiu P. Immunogenicity of inactiviated
bacines prepared with parainfluenza viruses type 1 and type 3, administered
experimentally by nasal or oral route. Rom J Virol 1998;49(1-4):97-115.
25. Haller AA, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of
human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel
attenuated virus vaccine vector. J Virol 2000;74(24):11626-35.
26. Muñoz FM, Englund JA. A step ahead. Infant protection through maternal
immunization. Pediatr Clin Nort Am 2000;47(2):449-63.
27. Gray GC, Goswami PR, Malasig MD, Hwasworth AW, Trump DH, Ryan MA, et al.
Adult adenovirus infections: loss or orphaned vaccines precipitates military respiratory
disease epidemics. For the adenovirus surveillance group. Clin Infect Dis
2000;31(3):663-70.
28. Hyer RN, Howell MR, Ryan MA, Gayudos JC. Cost-effectiveness analysis of
reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits. Am J Trop
Med Hyg 2000;62(5):613-8.
29. Hayden FG. Influenza virus and rhinovirus-related otitis media: potential for antiviral
intervention. Vaccine 2000;Suppl 1:S66-70.
30. Schultz J, Dollenmaier G, Molling K. Update on antiviral DNA vaccine research
(1998-2000). Intervirology 2000;43(4-6):197-217.
31. Bembridge GP, Rodriguez N, Garcia-Beato R, Nicolson C, Melero JA, Taylor G. DNA
encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces
protection in the absence of pulmonary inflammation. J Gen Virol 2000;81 Pt 10:251923.
32. Wong JP, Zabielski MA, Schmaltz FL, Brownlee GG, Bussey LA, Marshall K, et al.
DNA vaccination against respiratory influenza virus infection. Vaccine 2001;19(1719):2461-7.
33. Black S, Shinefield H. Issues and Challenges: Pneumococcal vaccination in pediatrics.
Ped Ann 1997;26:355-60.
34. Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.
Pneumoccocal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody
response in children with recurrent otitis madia acuta. J Infect Dis 1999;1179(5):11526.
35. Klein JO.
Management of otitis media: 2000 and beyond. Pediatr Infect Dis J.
2000;19(4):383-7.
36. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21
st century: global análisis of the disease burden 25 years after the use of the
polysaccharide vacine and a decade after the advent of conjugates. Clin Microbiol Rev
2000;13(2):302-17.
37. Burns IT, Zimmerman RK. Haemophilus influenzae type B disease, vaccines, and care
of exposed individuals. J Farm Pract 2000;49(9 Suppl):S7-13.
38. Rosenstein NE, Perkins BA. Update on Haemophilus influenzae serotype b and
meningococcal vaccines. Pediatr Clin North Am 2000;47(2):337.
39. Kyd J, Cripps A. Nontypeable haemophilus infoluenzae: challenges in developing a
vaccine. J Biotechnol 1999;73(2-3):103-8.
40. Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect
Dis J 1997;16:S78-84.
41. AAP. Committee on infectious diseases. Acellular pertussis vaccine: recommendations
for use as the initial series in infant and children. Pediatrics 1997;99:282-8.
42. Brandt ER, Good MF. Vaccine strategies to prevent rheumatic fever. Immunol Res
1999;19:89-103.
43. Dale JB. Group Streptococcal vaccines. Infect Dis Clin North Am 1999;13:227-43.
Recibido: 4 de marzo de 2001. Aprobado: 9 de septiembre de 2002.
Prof. Dr. Roberto Razón Behar. Hospital Pediátrico Universitario “William Soler”. San
Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.
T- 7
Referencias bibliográficas
1. Stites D, Terr A, Parslow T. Basic and clinical immunology. 8. ed. Connecticut: Appleton
and Lange, 1994:263.
2. Rosen FS, Cooper MD, Wedgwood RJP. The primary inmunodeficiencies. N Engl J Med
1995; 333(7)431-40.
3. Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9:722-8
4. Primary Immunodeficiency diseases. Report WHO Scientific Group. Clin Exp Immunol
1999;118 (Suppl) 1.
5. Behrman RE, Kliegma RM, Arvin AM. Tratado de Pediatría Ed. McGraw Hill
Interamericana 1998:720.
6. Buckley RH. Immunodeficiency Diseases. JAMA. 1992;268(20):2797-06.
7. Gungor T, Buhring I, Cremer R, Gartenschlager M, Zielen S. [Pathogenesis, diagnosis,
clinical and therapeutic aspects of ataxia telangiectasia] Klin Paediatr 1997 SepOct;209(5):328-35.
8. Nelson DL, Kurman CC. Molecular Genetic analysis of the primary immunodeficiency
Disorders. Ped Clin North America 1994; 41(4):657-64.
9. Davies EG. Infection in patients with primary immunodeficiencies diseases. Curr Op Infect
Dis 2000;13(4):349-53
10. Ballow M. Primary Immnunodeficiency. Antibody deficiency. J All Clin Immunol
2002;109(4):581-91.
11. Stiehm ER. Immunological disorders in infants and children. 4 ed. Philadelphia: WB
Saunders, 1996: 201-52.
12. Fontán G. Inmunodeficiencias primarias. Clínica y formas variantes. Allergol et
Inmunopathol.2001; (3): 101-125.
13. Cunningham-Rundles C. Common Variable Immunodeficiency. Curr Allergy Asthma Rep
2001; 1(5):421-9.
14. Nysrad W, Skrondal A, Magnus P. Day care attendance, recurrent respiratory tract infection
and asthma. Int J Epidemiol 1999; 28(5):882-7.
15. Celedon JC, Litonjua AA, Weis ST, Gold DR. Day care attendance in the first year of life
and illnesses of the upper and lower respiratory tract in children with a familial history of
atopy. Pediatrics 1999;104(pt 1):495-500.
16. Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S, Buckley
RH, Prose NS. Cutaneous complications of BCG vaccination in infants with immune
disorders: two cases and a review of the literature. Pediatr Dermatol 2001 MayJun;18(3):205-9.
17. Cunningham-Rundles C. Hematologic complications of primary immunodeficiency. Blood
Rev 2002; 16(1): 61-4.
18. Abonia JP. Common Variable Immunodeficiency. All Asthma Proc 2002; 23 (1):53-7
19. Mackay IR, Ritts RE. Use and abuse of 8 widely-used diagnostic procedures in clinical
immunology: a WHO Memorandum. Bullettin of the WHO1981;59(5):717-28.
20. Bloch
KJ,
Buckley
RH,
Kohler
PF.
Diagnostic laboratory immunology: a subspecialty that encompasses clinical as well as
laboratory immunology. J Allergy Clin Immunol 1991;Dec;88(6):961-3.
21. Buckley RH. Primary celular imunodeficiency. J All Clin Immunol 2002;109(5pt1):747-7.
22. -------------------.
Breakthroughs
in
the
understanding
and
therapy
of
Primary
Immunodeficiency. Ped Clin North Am 1994;41(4) 665-90.
23. Culver KW, Blaese RM. Gene therapy for Immunodeficiency Disease. New Concepts in
Immunodeficiency Diseases. Ed by S Gupta and C. Griscelli.1993:428.
24. Otsu M, Wanda T. Gene therapy for Primary Immunodeficiency. Current Opin Infect Dis.
2001; 1(6): 497-501.
25. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for
severe combined immunodeficiency in the neonatal period leads to superior thymic output
and improved survival. Blood 2002 Feb 1;99(3):872-8.
26. Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH. Thymic function
after
hematopoietic stem-cell transplantation for the treatment of severe combined
immunodeficiency. N Engl J Med 2000 May 4 ;342(18):1325-32.
27. Buckley RH. Advances in the understanding and treatment of human severe combined
immunodeficiency. Immunol Res 2000;22(2-3):237-51.
28. Eley BS, Hughes J, Cooper M, Pienaar S, Beatty DW. Primary immunodeficiency diseases at
Red Cross War Memorial Children Hospital. SAMJ 1997; 87(12): 1684-8.
29. Giraldo P. Inmunodeficiencias secundarias. Allergol et Inmunopathol.2001; (3): 155-161.
30. Klein M. CVI newswatch, 1999;issue No.1:1-3.
31. CLIC-AAAAI. Practice parameters for the diagnosis and management of immunodeficiency.
Ann Allergy Asthma and Immunology. 1996;76(3):282-94.
32. Programme of control of Acute respiratory Infections. Fourth. Programme Report 1988 1989. WHO, ARF, 1992; 90: 7 - 32.
33. Wahlgren DR, Hovell MF, Meltzer EO, Meltzer SB. Involuntary smoking and asthma. Curr
Opin Pulm Med 2000 Jan;6(1):31-6.
34. Corbo GM, Forastiere F, Dell'Orco V, Pistelli R, Agabiti N, De Stefanis B, Ciappi G, Perucci
. Effects of environment on atopic status and respiratory disorders in children. J Allergy Clin
Immunol 1993 Oct;92(4):616-23.
35. Infante-Rivard
C.
Childhood
asthma
and
indoor
environmental
risk
factors.
Am J Epidemiol 1993 Apr 15; 137(8):834-44.
36. Forastiere F, Agabiti N, Corbo GM, Dell'Orco V, Porta D, Pistelli R, Levenstein S, Perucci
CA. Socioeconomic status, number of siblings, and respiratory infections in early life as
determinants of atopy in children. Epidemiology 1997 Sep;8(5):566-70.
37. Lang T1 Lafaix C, Fassin D , Arnault. Y, Salmon B. Acute respiratory infections : a
longitudinal study of 151 children in Burquina - Faso. Int. J. Epidemiol 1986 ; 15 4:
553 - 60 .
38. Ballard TJ, Neuman CG. The Effects of Malnutrition , Parenteral Literacy and
Household Crowding on Acute Lower Respiratory . Infections in young Kenyan
Children Journal of Tropical Pediatrics 1995; 41 : 8 -12.
39. Tupasi TE Malnutrition and Acute respiratory tract infections in Filipino children. Rev.
Infect. Dis 1990; 12 suppl 8: 1047 - 54.
40. Nystad W, Skrondal A, Magnus P. Day care attendance, recurrent respiratory tract infections
and asthma. Int J Epidemiol 1999 Oct; 28(5):882-7
41. Deb S. Acute respiratory disease survey in Tripura in case of children below five years of
age. J Indian Med Assoc 1998 Apr; 96(4):111-6 .
42. Castro-Rodríguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ.
Association of radiologically ascertained pneumonia before age 3 yr with asthmalike
symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit
Care Med 1999 Jun;159(6):1891-7
43. Youssef Fasheh W, Esquinas Rychen G. The middle lobe syndrome in pediatrics. A study of
27 cases]. An Esp Pediatr 1998 Dec;49(6):582-6 .
44. Pons Pedro A. Enfermedades del Aparato Respiratorio / Pedro A. Pons.- Barcelona: Ed.
SALVAT, 1968: 501.
45. del Rosario JF, Orenstein SR. Evaluation and management of gastroesophageal reflux and
pulmonary disease. Curr Opin Pediatr 1996 Jun;8(3):209-15 .
46. Guill MF. Respiratory Manifestations of Gastroesophageal Reflux in Children. J of Asthma.
1995; 32(3), 173-189.
47. Anuario Estadístico 1998. Dirección Nacional de Estadística. MINSAP. La Habana, CUBA.
Recibido: 10 de abril de 2003. Aprobado: 26 de junio de 2003.
Dra. María Victoria Guntiñas Zamora. Avenida de la Ceiba esq. a 2da. Casino Deportivo.
Ciudad de La Habana, Cuba. Habana 34. Cod. Postal 13400.
T-8
Referencias bibliográficas
1. Lake CL. Pediatric cardiac anesthesia. Second Edition. Norwalk: Ed. Appleton & Lange,
1993
2. Gregory GA. Pediatric anesthesia. 4th ed. New York: Ed. Churchill-Livingstone, 2002.
3. Kaplan J. Cardiac anesthesia. Fourth Edition. Philadelphia: Ed. Churchill- Livingstone, 1999.
4. De la Parte PL, Hernández SB, Pérez PI. Anestesia en los defectos septales. Rev Cubana
Pediatr 1995; 67(3):174 -80.
5. De la Parte PL, Hernández SB, Pimienta P. Anestesia en la comunicación interventricular del
lactante. Rev Cubana Cir 1995;34 (1):31-40.
6. De la Parte PL. Anestesia en el síndrome de Down con canal auriculoventricular común. Rev
Cubana Pediatr 1995;67(2):97-102.
7. Barash GP. Clinical Anesthesia. 4th ed. Philadelphia: Ed. Lippincott Williams & Wilkins,
2001.
8. De la Parte PL, Hernández SB, Carballés GF. Anestesia en la ventana aortopulmonar. Rev
Cubana Pediatr 2001;73(2):81-5.
9. De la Parte PL. Anestesia en la coartación de la aorta. Rev Cubana Pediatr 2001; 73(4):21523.
10. Gal TJ. Reactive Airway disease: Anesthetic perspectives. IARS 2002 Review Course Lectures.
Suppl. to Anesthesia & Analgesia 2002(March):45-53.
11. Gruber EM, Laussen PC, Casta A. Stress response in infants undergoing cardiac surgery: a
randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion.
Anesth & Analg 2001;92(4):882-90.
12. Duncan HP, Cloote A, Weir PM. Reducing stress response in the pre-bypass phase of open
heart surgery in infants and young children: a comparison of different fentanyl doses. British J
Anaesth 2000;84:556-64.
13. Lake CL. Fast Tracking in paediatric Cardiac anaesthesia: An update. Annals Cardiac
Anaesthesia 2002;5:203-08.
14. De la Parte PL. Valor del Rocuronio en la intubación nasotraqueal del niño cardiópata. Rev
Cubana Pediatr 2002;74(2):145-50.
15. Andropoulos D, Bent S. The optimal length of insertion of central venous catheters for
pediatric patients. Anesth Analg 2001;93:883-6.
Recibido: 29 de julio de 2003. Aprobado: 29 de septiembre de 2003.
Dr. Lincoln de la Parte Pérez. Hospital Pediátrico Universitario “William Soler”. San Francisco
y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.
Correo: lincoln.delaparte@infomed.sld.cu
T-9
Referencias bibliográficas
1. Ohtahara S, Ishida T, Oka E, Yamatogi Y, Inoue H. On the specific age-dependent epileptic
syndrome. The early-infantile epileptic encephalopathy with suppression-burst. No-ToHattatsu (Tokyo) 1976;8:270-80.
2. Engel J Jr. ILAE Commission Report. A proposed diagnostic scheme for people with
epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and
Terminology. Epilepsia 2001;42:1-8.
3. Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E, Inoue H. L’encéphalopathie épileptique
infantile précoce avec “suppression-burst”. En Roger J, Bureau M, Dravet C, Dreifuss FE,
Perret A, Wolf P, eds. Les syndromes épileptiques de l’enfant et de l’adolescent. 2e ed.
London: John Libbey,1992: 25-34.
4. Yelin K, Alfonso I, Papazian O. Síndrome de Ohtahara. Rev Neurol 1999;29:340-2.
5. Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E. The early-infantile epileptic encephalopathy
with suppression- burst:developmental aspects. Brain Dev 1987;9: 371-6.
6. Yamatogi Y, Ohtahara S. Early –infantile epileptic encephalopathy with suppression-bursts,
Ohtahara syndrome; its overview referring to our 16 cases. Brain Dev 2002;24:13-23.
7. Hoefer PFA, de Napoli RA, Lesse S. Periodicity and hypsarrhythmia in the EEG. Arch
Neurol 1963;9:424-36.
8. Ohtahara S, Yamatogi Y. Evolution of seizures and EEG abnormalities in childhood onset
epilepsy. En Wada JA, Ellingson RJ, eds. Clinical neurophysiology of epilepsy EEG
handbook (revised series, vol 4 ). Amsterdam: Elsevier, 1990:457-77.
9. Bermejo AM, Martin VL, Arcas J, Pérez-Higueras A, Morales C, Pascual Castroviejo I.
Early infantile epileptic encephalopathy: a case associated with hemimegalencephaly. Brain
Dev 1992;14:425-8.
10. Robain O, Dulac O. Early epileptic encephalopathy with suppression bursts and olivarydentate dysplasia. Neuropediatrics 1992;23:162-4.
11. Campistol J, García-García JJ, Lobera E, Sanmarti FX, Conill J, Fernández-Alvarez E.
Síndrome de Ohtahara: una forma de epilepsia edad-dependiente. Rev Neurol 1997;25:2124.
12. González de Dios J, Moya M, Pastore C, Izura V, Carratalá F. Encefalopatía epiléptica
infantil precoz y encefalopatía glicinémica. Rev Neurol 1997;25:1916-18.
13. Williams AN, Gray RG, Poulton K, Ramani P, Whitehouse WP. A case of Ohtahara
syndrome with cytochrome oxidase deficiency. Dev Med Child Neurol 1998;40:568-70.
14. Trinka E, Rauscher C, Nagler M, Moroder T, Ladurner G, Irnberger E, et al. A case of
Ohtahara syndrome with olivary-dentate dysplasia and agenesis of mamillary bodies.
Epilepsia 2001;42:950-3.
15. Itoh M, Hanaoka S, Sasaki M, Ohama E, Takashima S. Neuropathology of early-infantile
epileptic encephalopathy with suppression-bursts: comparison with those of early myoclonic
encephalopathy and West syndrome. Brain Dev 2001;23:721-6.
16. Dulac O. Epilepsies et convulsions de l’enfant. Encycl Méd Chir Pédiatrie. Paris: Elsevier,
1998:1-26.
17. Ohno M, Shimotsuji Y, Abe J, Shimada M, Tamiya H. Zonisamide treatment of early
infantile epileptic encephalopathy. Pediatr Neurol 2000;23:341-4.
18. Aicardi J, Goutières F. Encéphalopathie myoclonique néonatale. Rev EEG Neurophysiol
1978;8:99-101.
19. Harris R, Tizard JPM. The electroencephalogram in neonatal convulsions. J Pediatr
1960;57:501-20.
20. Dreyfus-Brisac C, Monod N. Electro-clinical studies of status epilepticus and convulsions in
the newborn. En: Kellaway P, Petersen I, eds. Neurological and electroencephalographic
correlative studies in infancy. New York: Grune and Stratton, 1964:251-72.
21. Pozo D, Camejo A, Moreno O. The diagnostic and prognostic value in perinatal asphyxia. Z
Klin Med 1990;22:1979-80.
22. Aicardi J. Encéphalopathie myoclonique précoce (encéphalopathie myoclonique néonatale).
En : Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Les syndromes
épileptiques de l’enfant et de l’adolescent.2e ed. London: John Libbey, 1992:13-23.
Recibido: 3 de junio de 2003. Aprobado: 28 de julio de 2003.
Dra. Albia J. Pozo Alonso. Servicio de Neuropediatría. Hospital Pediátrico Universitario
“William Soler”. San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.
Correo electrónico: albiap@infomed.sld.cu
T-10
Referencias bibliográficas
1. Avila ML, Odio CM. Enfermedad por arañazo de gato (linforreticulosis benigna por
inoculación) en: Meneghello J, Fanta E, Paris E, Puga TF. Pediatría. 5a ed. Buenos Aires: Ed.
Panamericana 1997; 849-51.
2. Schutze GE. Diagnóstico y tratamiento de las infecciones por Bartonella henselae. .Pediatr
Infect Dis J 2000; 16: 1185-8.
3. Wear DJ, Margilein AM, Hadfield TL, Fisher GW, Schlagel CJ, King FM. Cat scratch
disease: a bacterial infection. Science 1983; 221: 1403-5.
4. Brenner DJ, O’Connor SP, Winkler HH, Steirgerwait AG. Proposal to unify the genera
Bartonella and vinsonii comb. nov, Bartonella henselae comb. nov, and Bartonella elizabethae
comb. nov. and remove the family Bartonellaceae from the order Rickettsiales. In J Syst
bacterial 1993; 43: 777-86.
5. Cruz AM, Vila AJ, Saa Requejo, Muñoz JC. Enfermedad por arañazo de gato. Centro de
Salud 2001; +9: 152-5.
6. Frandson JM, J Rawlings, Burgess CR, Hendricks KA. Cat scratch disease in Texas. Infect
Med 2000; 17: 690-94.
7. Giladi M, Avidor B. Cat scratch disease. N Eng J Med 1999; 340: 108.
8. Whitman BW, Krafte-Jacobs B. Cat scratch disease associated whit pleural effusions and
encephalopathy in a child. Respiration 1995; 62: 171-3.
9. Anlemnmes P, Leroy J, Estavoyer JM, Destuynder O, Aubert D, Vienet G, et al. A little know
cause of persistent fever and granulomatous hepatitis in children: cat scratch disease. Arch
Pediatr 1995; 2: 657-661.
10. Abbasi S. pulmonary manifestation of cat scratch disease. Pediatr Infect Dis J 1995; 14: 5478.
11. Smith DL. Cat scratch disease and related clinical syndromes. Am Fam Physician 1997; 55:
1783-9, 1794.
12. Donnelly A, Hendricks G, Martens S, Strovers C, Wiemerslage S, Thomas PA. Cytologic
diagnosis of cat scratch disease (CSD) by fine-needle aspiration. Diagnostic Cytopathology
1995; 13:103-6.
13. Ferrer R. Linphadenopathy: differential diagnosis and evaluation. Am Fam Physician 1998;
58:1313-22.
14. Enfermedad por arañazo de gato. Diagnóstico mediante reacción en cadena de la polimerasa.
Actas Dermo-Sifiliográficas 2000; 91: 395-9.
15. Segura-Corrales J, Bosch-Aparici X, Bosch-Mestre J, Sole-Arques M, Martínez-Orozco F.
Enfermedad por arañazo de gato. Presentación de dos casos familiares con seguimiento
serológico y discusión de métodos diagnósticos. Rev Clin Esp 1998; 198: 360-3.
16. Bolhmann BJ. Treatment of cat scratch disease (comment, letter). N Eng J Med 1999; 340.
1842.
17. Walterspiel JN. Treatment of cat scratch disease (letter). N Eng J Med 1999; 340:1842-3.
18. Giladi M, Ephros M. Treatment of cat scratch disease (letter). N Eng J Med 1999; 340:1843.
19. Bodino JA. Enfermedad recurrente por arañazo de gato. En: Datos interesantes publicados
recientemente. Revista de Enfermedades Infecciosas en Pediatría, 1999; vol XI (49): 293.
Recibido: 15 de abril de 2003. Aprobado: 21 de julio de 2003.
Dra. Ileana Alvarez Lam. Hospital Pediátrico Universitario “William Soler”, San Francisco y
Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.